Published in Curr Opin Microbiol on December 29, 2013
Interleukin-22 regulates the complement system to promote resistance against pathobionts after pathogen-induced intestinal damage. Immunity (2014) 2.37
Changes in bacterial community composition of Escherichia coli O157:H7 super-shedder cattle occur in the lower intestine. PLoS One (2017) 1.40
Microbial activities and intestinal homeostasis: A delicate balance between health and disease. Cell Mol Gastroenterol Hepatol (2015) 1.00
Hospitalization Type and Subsequent Severe Sepsis. Am J Respir Crit Care Med (2015) 0.93
Vegetable microbiomes: is there a connection among opportunistic infections, human health and our 'gut feeling'? Microb Biotechnol (2014) 0.86
Analysis of Bacterial Communities during Clostridium difficile Infection in the Mouse. Infect Immun (2015) 0.86
Colonization Resistance of the Gut Microbiota against Clostridium difficile. Antibiotics (Basel) (2015) 0.82
Colonization with the enteric protozoa Blastocystis is associated with increased diversity of human gut bacterial microbiota. Sci Rep (2016) 0.79
Antibiotic exposure perturbs the gut microbiota and elevates mortality in honeybees. PLoS Biol (2017) 0.78
Human Microbiota of the Argentine Population- A Pilot Study. Front Microbiol (2016) 0.78
Understanding Long-Term Outcomes Following Sepsis: Implications and Challenges. Curr Infect Dis Rep (2016) 0.76
Microorganisms in Confined Habitats: Microbial Monitoring and Control of Intensive Care Units, Operating Rooms, Cleanrooms and the International Space Station. Front Microbiol (2016) 0.76
Novel Indications for Fecal Microbial Transplantation: Update and Review of the Literature. Dig Dis Sci (2017) 0.76
DNA replication proteins as potential targets for antimicrobials in drug-resistant bacterial pathogens. J Antimicrob Chemother (2017) 0.75
Clinical Evidence for the Microbiome in Inflammatory Diseases. Front Immunol (2017) 0.75
Culture independent assessment of human milk microbial community in lactational mastitis. Sci Rep (2017) 0.75
Citrobacter rodentium mouse model of bacterial infection. Nat Protoc (2016) 0.75
Diversity of the human intestinal microbial flora. Science (2005) 49.64
A human gut microbial gene catalogue established by metagenomic sequencing. Nature (2010) 43.63
Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med (2013) 20.65
An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature (2007) 10.92
NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell (2011) 9.75
Microbial culturomics: paradigm shift in the human gut microbiome study. Clin Microbiol Infect (2012) 7.97
Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol (2009) 7.89
Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol (2007) 7.58
Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature (2010) 6.25
Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis (2008) 6.21
Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol (2010) 5.57
The gut microbiota--masters of host development and physiology. Nat Rev Microbiol (2013) 5.25
Host-induced epidemic spread of the cholera bacterium. Nature (2002) 5.20
Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med (2000) 5.08
Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest (2010) 4.95
Microbiology in the post-genomic era. Nat Rev Microbiol (2008) 4.88
Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice. Proc Natl Acad Sci U S A (2011) 4.85
Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature (2013) 4.43
Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol (2013) 4.34
Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell Host Microbe (2009) 4.20
The keystone-pathogen hypothesis. Nat Rev Microbiol (2012) 4.18
Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science (2012) 4.17
Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat Genet (2012) 4.10
Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog (2012) 3.81
Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect Immun (2008) 3.68
Diet, gut microbiota and immune responses. Nat Immunol (2011) 3.66
Human intestinal bacteria as reservoirs for antibiotic resistance genes. Trends Microbiol (2004) 3.64
Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science (2013) 3.54
Antibiotic treatment of clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts. Infect Immun (2009) 3.36
Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe (2007) 3.28
Evolutionary dynamics of Clostridium difficile over short and long time scales. Proc Natl Acad Sci U S A (2010) 3.18
The role of microbiota in infectious disease. Trends Microbiol (2008) 3.11
Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis. Infect Immun (2011) 2.87
Host transmission of Salmonella enterica serovar Typhimurium is controlled by virulence factors and indigenous intestinal microbiota. Infect Immun (2007) 2.80
Like will to like: abundances of closely related species can predict susceptibility to intestinal colonization by pathogenic and commensal bacteria. PLoS Pathog (2010) 2.79
Shifting the balance: antibiotic effects on host-microbiota mutualism. Nat Rev Microbiol (2011) 2.43
The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile Infection. Gut Microbes (2011) 2.37
Meta-analyses of studies of the human microbiota. Genome Res (2013) 2.35
Lethal inflammasome activation by a multidrug-resistant pathobiont upon antibiotic disruption of the microbiota. Nat Med (2012) 2.20
Intestinal short-chain fatty acids alter Salmonella typhimurium invasion gene expression and virulence through BarA/SirA. Mol Microbiol (2002) 2.18
The microbiota mediates pathogen clearance from the gut lumen after non-typhoidal Salmonella diarrhea. PLoS Pathog (2010) 2.17
The Clostridium difficile spo0A gene is a persistence and transmission factor. Infect Immun (2012) 2.02
The transcription factor T-bet regulates intestinal inflammation mediated by interleukin-7 receptor+ innate lymphoid cells. Immunity (2012) 1.97
Community-wide response of the gut microbiota to enteropathogenic Citrobacter rodentium infection revealed by deep sequencing. Infect Immun (2009) 1.91
Gut inflammation can boost horizontal gene transfer between pathogenic and commensal Enterobacteriaceae. Proc Natl Acad Sci U S A (2012) 1.90
Genes induced late in infection increase fitness of Vibrio cholerae after release into the environment. Cell Host Microbe (2007) 1.90
Mechanisms controlling pathogen colonization of the gut. Curr Opin Microbiol (2010) 1.88
Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization. Infect Immun (2013) 1.85
Intestinal colonization resistance. Immunology (2013) 1.85
Suppression of Clostridium difficile in the gastrointestinal tracts of germfree mice inoculated with a murine isolate from the family Lachnospiraceae. Infect Immun (2012) 1.79
A composite bacteriophage alters colonization by an intestinal commensal bacterium. Proc Natl Acad Sci U S A (2012) 1.64
Butyrate specifically down-regulates salmonella pathogenicity island 1 gene expression. Appl Environ Microbiol (2006) 1.57
'Blooming' in the gut: how dysbiosis might contribute to pathogen evolution. Nat Rev Microbiol (2013) 1.45
Chemical sensing in mammalian host-bacterial commensal associations. Proc Natl Acad Sci U S A (2010) 1.32
Increased susceptibility to vancomycin-resistant Enterococcus intestinal colonization persists after completion of anti-anaerobic antibiotic treatment in mice. Infect Control Hosp Epidemiol (2004) 1.30
The streptomycin mouse model for Salmonella diarrhea: functional analysis of the microbiota, the pathogen's virulence factors, and the host's mucosal immune response. Immunol Rev (2012) 1.30
Emergence of a 'hyperinfectious' bacterial state after passage of Citrobacter rodentium through the host gastrointestinal tract. Cell Microbiol (2005) 1.25
Formate acts as a diffusible signal to induce Salmonella invasion. J Bacteriol (2008) 1.18
Enterococcus faecalis prophage dynamics and contributions to pathogenic traits. PLoS Genet (2013) 1.13
Altering host resistance to infections through microbial transplantation. PLoS One (2011) 1.12
Detection of Actinobacteria cultivated from environmental samples reveals bias in universal primers. Lett Appl Microbiol (2007) 1.09
Enteric pathogen exploitation of the microbiota-generated nutrient environment of the gut. Curr Opin Microbiol (2011) 1.09
Bacteriotherapy for the treatment of intestinal dysbiosis caused by Clostridium difficile infection. Curr Opin Microbiol (2013) 0.90